ArriVent BioPharma, Inc. AVBP Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s net change in cash?
- ArriVent BioPharma, Inc. (AVBP) reported net change in cash of $16.56M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s net change in cash changed year-over-year?
- ArriVent BioPharma, Inc.'s net change in cash increased by 167.8% year-over-year, from -$24.43M to $16.56M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.